ANKTIVA
Live / Applied — Statement of use — registration review complete (as of 05 Nov 2026)
What this means for you
Not registered yet, but its 18 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97759978
- Mark type
- Word mark
- Filed
- 18 Jan 2023
- Published for opposition
- 03 Oct 2023
- Attorney of record
- Michael J. McCue
Goods and services
- Class 042 — Scientific and technological services: Medical research and product development; pharmaceutical research and development services; medical and scientific research in the fields of pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, infectious diseases, human diseases, animal diseases; product development in the fields of pharmaceuticals, oncology, cancer, immune-oncology, immunotherapy, infectious diseases, human diseases and animal diseases
Owner
- Altor BioScience, LLC, Culver City, CA, US
- Altor BioScience, LLC, Culver City, CA, US
Prior registrations
Prosecution history
- 05 Nov 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Nov 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Oct 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 12 Oct 2026 — USE AMENDMENT FILED
- 12 Oct 2026 — TEAS STATEMENT OF USE RECEIVED
- 29 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 May 2026 — SOU EXTENSION 5 GRANTED
- 25 May 2026 — SOU EXTENSION 5 FILED
- 26 May 2026 — SOU TEAS EXTENSION RECEIVED
- 27 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Nov 2025 — SOU EXTENSION 4 GRANTED
- 26 Nov 2025 — SOU EXTENSION 4 FILED
- 26 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 May 2025 — SOU EXTENSION 3 GRANTED